A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council investigation

Tubercle. 1974 Mar;55(1):1-27. doi: 10.1016/0041-3879(74)90064-6.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Antibodies / analysis
  • Clinical Trials as Topic
  • Drug Administration Schedule
  • Drug Eruptions / etiology
  • Drug Therapy, Combination
  • Dyspnea / chemically induced
  • Ethambutol / administration & dosage*
  • Ethambutol / adverse effects
  • Female
  • Humans
  • Jaundice / chemically induced
  • Male
  • Middle Aged
  • Radiography
  • Rifampin / administration & dosage*
  • Rifampin / adverse effects
  • Rifampin / immunology
  • Sputum / microbiology
  • Tuberculosis, Pulmonary / diagnostic imaging
  • Tuberculosis, Pulmonary / drug therapy*
  • Tuberculosis, Pulmonary / microbiology

Substances

  • Antibodies
  • Ethambutol
  • Rifampin